[ad_1]
Pascal Soriot, Director of AstraZeneca. Photo by Chris Kleponis (Imago / Scanpix)
Pascal Soriot, director of AstraZeneca, said that the interruption in the distribution of the coronavirus vaccine in EU countries was due to the approval by the European Union of the use of the vaccine by the company.
Production is basically a little behind the situation by two months, he told the Italian daily La Repubblica, the BBC reports.
According to him, due to the late EU decision, there is little time left to resolve supply difficulties. The Swedish and British company team is open 24 hours a day. 24 hours a day, 7 days a week, P. Soriotas emphasizes that many problems related to vaccine production have been solved. An additional problem with increased vaccine production, he said, arose at two plants in the Netherlands and Belgium.
He said the company was facing major concerns in the UK supply chain. However, the UK deal was signed 3 months before the EU deal, giving it three more months to rectify any deficiencies, Soriot said.
The UK approved the AstraZeneca vaccine on December 30 last year and vaccination started in early January.
A decision from the EEA on the EU authorization of AstraZeneca is expected on January 29.
After the spjim increased the planned amount
At an early stage, a wide range of issues need to be addressed. We hope we have solved them, but basically we are two months away from where we wanted, ”said the head of AstraZeneca.
He said the vaccine maker would deliver millions of doses to Europe in the summer.
It is clear that AstraZeneca has sparked a major European Union leader and some countries are angry after announcing on Friday that the EU will spend 31 million euros in the first quarter. doses of vaccine, instead of the expected 80 million, on the grounds that less vaccine will be produced in a factory in Belgium.
The European Commission issued a strong warning to the company and demanded that EU inspectors have access to the company’s accounts to verify production and delivery numbers.
The President of the European Commission, Ursula von der Leyen, reminded AstraZeneca CEO Soriot on Monday of the company’s responsibilities. Italy and some other EU countries, on the other hand, are aware of the possibility of shipping supplies to both the company and Pfizer, which has previously announced vaccine supply exchange plans.
Following the warning, AstraZeneca on Tuesday announced an increase in expected delivery of the vaccine through the summer. This was confirmed by Gytis Andrulionis, head of the Lithuanian State Drug Control Service (IARC), as reported by BNS.
Rayti komentar
[ad_2]
